Category: Providers

Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

Adventist Health System/West alleged in a lawsuit that four major drugmakers defrauded the federal government by overcharging for 340B drugs.

A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Jazz Pharmaceuticals Exempt States from 340B Contract Pharmacy Restrictions — Including First for Missouri

July 23, 2024 William Newton, Associate Editor/Senior Writer Views

Merck became the first drugmaker to announce it would loosen its 340B contract pharmacy restrictions in Missouri in response to a new state law.

Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Massachusetts 340B Measures Addressing PBM Discrimination and Medicaid Drug Coverage Fall Short in Senate, Sponsor Plans to Refile Bill Next Session

July 19, 2024 Shannon Young, Associate Editor/Senior Writer Views

A contract pharmacy access bill could still pass in Massachusetts despite the end of the formal legislative session.

The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

July 18, 2024 William Newton and Shannon Young, Associate Editor/Senior Writer Views

Federal district courts in Maryland and Mississippi saw various legal actions related to state 340B contract pharmacy access laws in the past week.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

July 18, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Allows for Immediate 340B Enrollment in Texas Due to Hurricane; Hawaii Remains Eligible

July 18, 2024 William Newton, Associate Editor/Senior Writer Views

Due to Hurricane Beryl, certain Texas providers can immediately enroll in the 340B program without waiting for the normal registration period.

Eligible providers in Texas can now immediately enroll in the 340B program without waiting for the normal quarterly registration period [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sen. Cassidy Claims 340B Hospitals Drive Medical Debt During Key Senate Committee Hearing

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R) said many major nonprofit hospitals are "not passing on savings from 340B" in a Senate committee hearing on medical debt.

Certain hospitals’ failure to pass 340B savings on to patients is a leading cause of medical debt, two Republican lawmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.

The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder

July 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.

The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Upcoming Federal Elections Will Significantly Impact 340B Legislative Agenda, Say 340B Hospital Lobbyist, Drug Industry Analyst

July 11, 2024 William Newton, Associate Editor/Senior Writer Views

Tom O’Donnell, senior vice president of government relations at 340B Health, and Michael McCaughan, co-founder of Provision Policy, gave a July 10 address at the 340B Coalition summer conference.

The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live